HAVCR2 and acute myeloid leukemia: Soluble Tim-3 and Gal-9 molecules released by AML blasts inhibit CD8+ T-cell expansion [65] as well as interactions (notably though VISTA molecules) with myeloid-derived suppressor cells (MDSC) which increase in the PB during AML [66,67].